Created at 2:31 p.m. Jul, 27, 2026
Author: ronin16319
Related Note: 1509300563305 1
Rationale for change

Edited c2 to make it clear that the card is look for a range of values. Will save not know how to grade the card if you were to just answer "5" or "14" alone.

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
Empty field
One by one
Empty field
#AK_Other::Only_Step_1 #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::07_TNF_Alpha_Inhibitors_And_Monoclonal_Antibodies #AK_Step1_v12::#UWorld::COMLEX::23853 #AK_Step2_v12::#UWorld::Step::20700 #AK_Step1_v12::#B&B::13_Immunology::02_Clinical_Immunology::01_Hypersensitivity::Extra #AK_Step2_v12::#B&B::08_Infectious_Disease::01_Antibiotics::01_Penicillins::Extra #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::18_Anticancer_monoclonal_antibodies::*Rituximab::Basics #AK_Step2_v12::#NBME::Form11::Section_1 #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::18_Anticancer_monoclonal_antibodies::*Cetuximab_Panitumumab #AK_Step1_v12::#UWorld::Step::7656 #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::19_Rituximab #AK_Step1_v12::#OME::PreClinical::Immunology #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#UWorld::Step::741 #AK_Step1_v12::#Physeo::09_Pharm::09_Musculoskeletal::09_TNF-alpha_Inhibitors #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::03_Kinase_Inhibitors_&_Monoclonal_Antibodies::02_Monoclonal_Antibody_Therapy #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::17_Cetuximab/Panitumumab #AK_Step1_v12::#UWorld::COMLEX::106913 #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::12_TNF_Inhibitors_((Infliximab/Adalimumab/Certolizumab/Golimumab) #AK_Step2_v12::#UWorld::COMLEX::108595 #AK_Step1_v12::#Bootcamp::Immunology::11_Hypersensitivities::04_Type_III_Hypersensitivity_Reactions #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::*Basics #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield